Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death Unlisted Video
3 years ago
204
Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.
He explained "According to the most likely scenario, we will not have a vaccination before the end of next year."
Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.
An antibody test, which could be available as early as May, would determine whether someone has had the COVID-19 infection.
If so, they would have assumed ongoing immunity to the virus.
Schwan said that an antibody test is key to allowing businesses to reopen and for people to gradually return to normal life.
Loading 3 comments...
-
1:14
Newsy
3 years agoStudy: Hydroxychloroquine May Increase Death Risk In COVID-19 Patients
1.37K6 -
3:39
WXYZ
3 years agoLarge study finds hydroxychloroquine COVID-19 treatments linked to greater risk of death and heart arrhythmia
136 -
2:45
KTNV
4 years agoUMC using hydroxychloroquine for COVID-19 patients
1.53K2 -
2:14
KSHB
4 years agoCOVID-19 leads to hydroxychloroquine shortage for patients with autoimmune disease
151 -
1:56
Newsy
3 years agoStudy Suggests Hydroxychloroquine Has No Benefits In COVID-19 Cases
3.87K2 -
1:31
Newsy
3 years agoStudy Shows COVID-19 Patients Did Not Benefit From Hydroxycholoroquine
3281 -
0:58
Newsy
3 years agoU.K.'s COVID-19 Death Toll In Early April Higher Than Reported
852 -
2:34
WCPO
4 years agoHealthcare workers at higher risk of COVID-19
19 -
1:08
Newsy
4 years agoNew Study Links Soda Consumption To Higher Risk Of Death
185 -
2:04
KGUN
4 years agoDeaths with COVID-19 primarily in patients transferred to ICU
84